Download FREE Report Sample
Download Free sampleAttention-deficit/hyperactivity disorder (ADHD) is a disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development.
Inattention means a person wanders off task, lacks persistence, has difficulty sustaining focus, and is disorganized; and these problems are not due to defiance or lack of comprehension.
Hyperactivity means a person seems to move about constantly, including in situations in which it is not appropriate; or excessively fidgets, taps, or talks. In adults, it may be extreme restlessness or wearing others out with constant activity.
Impulsivity means a person makes hasty actions that occur in the moment without first thinking about them and that may have a high potential for harm, or a desire for immediate rewards or inability to delay gratification. An impulsive person may be socially intrusive and excessively interrupt others or make important decisions without considering the long-term consequences.
Attention-deficit Hyperactivity Disorder Therapeutics Market contains market size and forecasts of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics in Global, including the following market information:
The global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market was valued at 18360 million in 2021 and is projected to reach US$ 24470 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics include Pfizer, GSK, Eli Lilly, Novartis, Johnson & Johnson, Mallinckrodt, Hisamitsu, UCB and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segment Percentages, by Type, 2021 (%)
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segment Percentages, by Application, 2021 (%)
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
